← Scoopfeeds — Intelligent news, curated.
Citizens reiterates Taysha Gene Therapies stock rating on therapy progress
business

Citizens reiterates Taysha Gene Therapies stock rating on therapy progress

Investing.com · Jul 2, 2026, 9:08 AM · Also reported by 1 other source

Citizens reiterates Taysha Gene Therapies stock rating on therapy progress

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Morgan Stanley Reiterates Equal Weight Rating for Suncor Energy (SU)

More in business

CNBC
AI agents will soon be able to match human traders, Robinhood CEO tells CNBC
Bloomberg Markets
Investors Are Using Leveraged ETFs to Turbocharge AI Bets
BBC Business
Why the expected fight over the North American trade deal never kicked off
Investing.com
Why is Palantir stock rallying today?
Investing.com
Wall St futures subdued as investors await jobs data
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop